| Literature DB >> 30297910 |
Jahyun Koo1,2, Matthew R MacEwan3,4, Seung-Kyun Kang5,6, Sang Min Won7, Manu Stephen3, Paul Gamble3, Zhaoqian Xie2,8, Ying Yan3, Yu-Yu Chen7, Jiho Shin7, Nathan Birenbaum3,4, Sangjin Chung7, Sung Bong Kim7, Jawad Khalifeh3, Daniel V Harburg7, Kelsey Bean3, Michael Paskett3, Jeonghyun Kim9, Zohny S Zohny3, Seung Min Lee1,2, Ruoyao Zhang7, Kaijing Luo2,8, Bowen Ji2,8, Anthony Banks2,7, Hyuck Mo Lee10, Younggang Huang1,2,8, Wilson Z Ray11,12, John A Rogers13,14,15,16,17,18,19,20,21.
Abstract
Peripheral nerve injuries represent a significant problem in public health, constituting 2-5% of all trauma cases1. For severe nerve injuries, even advanced forms of clinical intervention often lead to incomplete and unsatisfactory motor and/or sensory function2. Numerous studies report the potential of pharmacological approaches (for example, growth factors, immunosuppressants) to accelerate and enhance nerve regeneration in rodent models3-10. Unfortunately, few have had a positive impact in clinical practice. Direct intraoperative electrical stimulation of injured nerve tissue proximal to the site of repair has been demonstrated to enhance and accelerate functional recovery11,12, suggesting a novel nonpharmacological, bioelectric form of therapy that could complement existing surgical approaches. A significant limitation of this technique is that existing protocols are constrained to intraoperative use and limited therapeutic benefits13. Herein we introduce (i) a platform for wireless, programmable electrical peripheral nerve stimulation, built with a collection of circuit elements and substrates that are entirely bioresorbable and biocompatible, and (ii) the first reported demonstration of enhanced neuroregeneration and functional recovery in rodent models as a result of multiple episodes of electrical stimulation of injured nervous tissue.Entities:
Mesh:
Year: 2018 PMID: 30297910 DOI: 10.1038/s41591-018-0196-2
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440